{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:05:05Z","timestamp":1781071505600,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is a prevalent malignancy with high morbidity and mortality. Immunotherapy benefits only a subset of patients, highlighting the need to explore immune-related signatures associated with response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We analyzed a single-cell RNA sequencing dataset of 27,414 cells from tumor core, edge, and matched normal mucosa to investigate NKT cell heterogeneity. A spatial transcriptomics dataset characterized interactions between NKT and Th1 cells in CRC tissues. Integrating nine CRC cohorts from TCGA and GEO, we assessed associations between NKT cell infiltration and clinical outcomes. NKT and Th1 cell\u2013related genes (NTRG) were identified and integrated into an NTRG score, which was systematically validated across multiple independent CRC cohorts to characterize its associations with survival and immunotherapy response. In addition to multi-database validation using several external transcriptomic datasets, we analyzed somatic mutation profiles, GO enrichment, and drug sensitivity patterns associated with different NTRG score groups. Furthermore, key NTRG genes were biologically validated in clinical CRC tissue specimens using immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elevated NKT cell infiltration correlated with improved prognosis and enhanced immunotherapy sensitivity. Spatial analysis revealed NKT and Th1 co-localization mediated by COLLAGEN signaling. The NTRG score quantified tumor\u2013immune properties, and high scores were linked with worse overall survival yet stronger immunotherapy response. Validation confirmed differential NTRG expression between normal and cancerous tissues and across immunotherapy responders and non-responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NTRG is an exploratory multi-gene signature associated with the immune landscape of colorectal cancer, offering a foundation for future investigation into its relationship with immunotherapy response and tumor microenvironmental organization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1774363","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:34Z","timestamp":1781070094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated single-cell and spatial transcriptomics reveal immune landscape and NKT\u2013Th1 signatures in colorectal cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Cunen","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihuiping","family":"Tao","sequence":"additional","affiliation":[{"name":"Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor","place":["Nanjing, Jiangsu, China"]},{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayue Darrel","family":"Duan","sequence":"additional","affiliation":[{"name":"The Academy of Phenomics of TCM, and School of Integrated Medicine, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Pharmacology, University of Nevada Reno School of Medicine","place":["Reno, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Zhao","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenlin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-yong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Tumor Systems Biology and Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Key Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the\u00a0global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00569-4","article-title":"Optimizing immunotherapy for colorectal cancer","volume":"19","author":"Ganesh","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.115","article-title":"NKT cell subsets as key participants in liver physiology and pathology","volume":"13","author":"Bandyopadhyay","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-1916","article-title":"Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and \u03b3\u03b4 T cells from hematopoietic stem cells","volume":"77","author":"Tie","year":"2017","journal-title":"Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-0734","article-title":"Activation of NKT cells in an anti-PD-1-resistant tumor model enhances antitumor immunity by reinvigorating exhausted CD8 T cells","volume":"78","author":"Bae","year":"2018","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-05-0877","article-title":"Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas","volume":"11","author":"Tachibana","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-17-0036","article-title":"Protumor steering of cancer inflammation by p50 NF-\u03baB enhances colorectal cancer progression","volume":"6","author":"Porta","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/med.21276","article-title":"Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells","volume":"34","author":"East","year":"2014","journal-title":"Med Res Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-15-1907","article-title":"Single-cell sequencing for precise cancer research: progress and prospects","volume":"76","author":"Zhang","year":"2016","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf5464","article-title":"Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer","volume":"9","author":"Wang","year":"2023","journal-title":"Sci Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.70389\/pjs.100082","article-title":"Transparency in the reporting of artificial intelligence - the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101611","article-title":"Clinical, molecular, and immune correlates of the immunotherapy response score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial","volume":"8","author":"Ferreiro-Pant\u00edn","year":"2023","journal-title":"ESMO Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00044-9","article-title":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1016\/j.cell.2021.11.031","article-title":"Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1184167","article-title":"Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/path.6228","article-title":"Genetic and immune landscape evolution in MMR-deficient colorectal cancer","volume":"262","author":"Challoner","year":"2024","journal-title":"J Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0345-y","article-title":"Thymic development of unconventional T cells: how NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge","volume":"20","author":"Pellicci","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B22","article-title":"Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells","volume":"59","author":"Kawano","year":"1999","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0034-2","article-title":"Tissue-specific functions of invariant natural killer T cells","volume":"18","author":"Crosby","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13104","article-title":"Human intestinal and circulating invariant natural killer T\u2009cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathway","volume":"15","author":"D\u00edaz-Basabe","year":"2021","journal-title":"Mol Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0772","article-title":"Spatial organization and prognostic significance of NK and NKT-like cells via multimarker analysis of the colorectal cancer microenvironment","volume":"10","author":"V\u00e4yrynen","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s40425-019-0697-7","article-title":"Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor","volume":"7","author":"Paul","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215959","article-title":"Th1-involved immune infiltrates improve neoadjuvant chemoradiotherapy response of esophageal squamous cell carcinoma","volume":"553","author":"Yuan","year":"2023","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.308","article-title":"Understanding cell-cell communication and signaling in the colorectal cancer microenvironment","volume":"11","author":"AlMusawi","year":"2021","journal-title":"Clin Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327913","article-title":"Novel TCF21high pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"B31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-018-0890-1","article-title":"Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis","volume":"17","author":"Ma","year":"2018","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-s1-p37","article-title":"Diverse somatic mutation patterns and pathway alterations in human cancers","volume":"466","author":"Kan","year":"2010","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1774363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:35Z","timestamp":1781070095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1774363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2026.1774363"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1774363","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1774363"}}